SYDNEY, Dec 20 (Reuters) - New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's (PFE.N) COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the heart muscle, after taking his first dose.
The death is New Zealand's second linked to a known but rare side effect from the vaccine after health authorities in August reported a woman had died after taking her doses. read more
"With the current available information, the board has considered that the myocarditis was probably due to vaccination in this individual," a COVID-19 Vaccine Independent Safety Monitoring Board said in a statement.
The man, who died within two weeks of his first dose, had not sought medical advice or treatment for his symptoms. Myocarditis is an inflammation of the heart muscle that can limit the organ's ability to pump blood and can cause changes in heartbeat rhythms.-- excerpt, rest at link above --
"I wish it need not have happened in my time," said Frodo.
"So do I," said Gandalf, "and so do all who live to see such times. But that is not for them to decide. All we have to decide is what to do with the time that is given us."
The Unfrozen Cave
»
»
All Things Wuhan Flu/Corona Virus/COVID-19
»
New Zealand links 26-year-old man's death to Pfizer COVID-19 vaccine
Unfrozen Cave Water Cooler
1
Print view
Mon Dec 20, 2021 11:22 am
reply